This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
By: MJ Alonso Lab
María José Alonso receives the ‘Sanitarias 2021 Prize’, awarded by Redacción Médica
March 4, 2021María José Alonso, Professor of Biopharmaceutics and Pharmaceutical Technology at the University of Santiago de Compostela (USC), has been recognized with the Burdinola Research Award, which has highlighted her outstanding work in the field of personalized and regenerative biomedicine in relation to nanomaterials and nanoparticles.
Read More
Eleni Samaridou receives the Suárez Freire Prize for young researchers awarded by the Royal Academy of Pharmacy of Galicia
February 26, 2021Our colleague Eleni Samaridou has just been recognized with the Julián Francisco Suárez Freire Prize for young researchers, awarded by the Royal Academy of Pharmacy of Galicia. Eleni Samaridou has received this award for a paper that describes a new nanotechnology which allows the delivery of microRNA (miRNA) from the nose directly to the brain, as a new therapeutic for Alzheimer’s disease, which has been published in the prestigious journal Biomaterials in 2020.
Read More
María José Alonso enters the Royal Academy of Medicine of Belgium as a Foreign Member
January 30, 2021María José Alonso, Professor of Biopharmaceutics and Pharmaceutical Technology at the University of Santiago de Compostela (USC), has entered the Royal Academy of Medicine of Belgium (ARMB) as Foreign Member. This is a new recognition of the outstanding career of Professor Alonso by international scientific institutions.
Read More
María José Alonso receives the Burdinola Research Award
January 25, 2021María José Alonso, Professor of Biopharmaceutics and Pharmaceutical Technology at the University of Santiago de Compostela (USC), has been recognized with the Burdinola Research Award, which has highlighted her outstanding work in the field of personalized and regenerative biomedicine in relation to nanomaterials and nanoparticles.
Read More
María José Alonso, recognized with the Honorific Award for Excellence in Scientific Research of the AstraZeneca Foundation
January 8, 2021The Honorific Award has been awarded since 2017 to clinical researchers with a proven career in biomedical research and who have contributed to the generation of knowledge and advances in their specialty and to the training of new researchers.
Read More
Libera Bio receives the Bioga Award for the Best Biotech Business Idea 2020
December 11, 2020Libera Bio is a spin-off of the Maria Jose Alonso’s lab at the University of Santiago de Compostela that develops anticancer drugs based on nanotechnology. The goal of its project is to address “undruggable” oncology targets by delivering whole antibodies inside the tumor and metastatic cells.
Read More
Engineering Anisotropic Meniscus: Zonal Functionality and Spatiotemporal Drug Delivery
October 20, 2020The authors acknowledge the original source of publication. Final publication is available from Mary Ann Liebert, Inc.: http://dx.doi.org/10.1089/ten.teb.2020.0096
Read More
Get free access to our latest paper: “Laser-induced transient skin disruption to enhance cutaneous drug delivery”
September 22, 2020Free access until November 07 to this article published in European Journal of Pharmaceutics and Biopharmaceutics.
Read More
María José Alonso receives the prestigious ‘Medal of Merit in Research and Education’ granted by the Government of Spain
July 28, 2020María José Alonso’s lab has pioneered numerous discoveries in the field of Pharmaceutical Nanotechnology and Nanomedicine. Her research is focused on designing novel nanostructured materials intended to transport drugs and antigens across biological barriers and deliver them to the target tissue, with the final goal of producing innovative nanomedicines and vaccines
Read More
Our latest paper, published in Frontiers in Immunology: “Arginine-Based Poly(I:C)-Loaded Nanocomplexes for the Polarization of Macrophages Toward M1-Antitumoral Effectors”
July 8, 2020Publication: Dacoba TG, Anfray C, Mainini F, Allavena P, Alonso MJ, Torres Andón F and Crecente-Campo J (2020) Arginine-Based Poly(I:C)-Loaded Nanocomplexes for the Polarization of Macrophages Toward M1-Antitumoral Effectors. Front. Immunol. 11:1412. doi: 10.3389/fimmu.2020.01412
Read More